{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:24:41Z","timestamp":1773894281059,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jaip.2017.04.044","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T03:17:27Z","timestamp":1497928647000},"page":"1425-1426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["First-dose anaphylaxis to infliximab: a case of mammalian meat allergy"],"prefix":"10.1016","volume":"5","author":[{"given":"Maithili","family":"Chitnavis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Commins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex J.","family":"Schuyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Behm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.04.044_bib1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ecco-jcc\/jjv096","article-title":"Infliximab-related infusion reactions: systematic review","volume":"9","author":"Lichtenstein","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.jaip.2017.04.044_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2133.2008.08728.x","article-title":"Review and expert opinion on prevention and treatment of infliximab-related infusion reactions","volume":"159","author":"Lecluse","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2017.04.044_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaci.2014.12.1947","article-title":"The alpha-gal story: lessons learned from connecting the dots","volume":"135","author":"Steinke","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.044_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaci.2004.12.1131","article-title":"Quantitative measurement of IgE antibodies to purified allergens using streptavidin linked to a high-capacity solid phase","volume":"115","author":"Erwin","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.044_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nbt.1912","article-title":"Anti-galactose-\u03b1-1,3-galactose IgE from allergic patients does not bind \u03b1-galactosylated glycans on intact therapeutic antibody Fc domains","volume":"29","author":"Lammerts van Bueren","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaip.2017.04.044_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4161\/mabs.19931","article-title":"Marketed therapeutic antibodies compendium","volume":"4","author":"Reichert","year":"2012","journal-title":"MAbs"},{"key":"10.1016\/j.jaip.2017.04.044_bib7","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2017.04.044_bib8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2008.10.052","article-title":"Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose","volume":"123","author":"Commins","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.044_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1586\/eci.11.27","article-title":"Mepolizumab in eosinophilic disorders","volume":"7","author":"Abonia","year":"2011","journal-title":"Expert Rev Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817303616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817303616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:12:30Z","timestamp":1761973950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817303616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2213219817303616"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.04.044","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-dose anaphylaxis to infliximab: a case of mammalian meat allergy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}